RAW MATERIAL DEVELOPMENT
If biological raw material is not commercially available to target your analyte NG Biotech will assure development and production of specific monoclonal or polyclonal antibodies.
|1- Feasibility and process design|
|2 – Immunization|
|3 – Screening, Selection & Purification|
|4 – Mass production|
Delay: 3 to 6 months